The global Frontotemporal Dementia Management Market is expected to garner a market value of US$ 10 Million in 2023 and is expected to accumulate a market value of US$ 17.91 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Frontotemporal Dementia Management registered a CAGR of 4% …
Category Archives: Healthcare Trends
Global Market for Tuberculous Meningitis Treatment to expand at a 7.2% CAGR from 2023 to 2033, reaching US$ 300 Billion: FMI Report
A recently published study by FMI expects the global tuberculous meningitis treatment market to augment at a 7.2% CAGR from 2023 to 2033. The global tuberculous meningitis treatment market garnered a market value of US$ 150 Billion in 2023, by the end of the said assessment period, a valuation of US$ 300 billion is expected for the market. Rapid advancements …
Idiopathic Pulmonary Fibrosis Management Market to Reach US$ 3649.90 Million by 2033: Focus on Developing New Drugs and Therapies | FMI
During the forecast period of 2023 to 2033, the global idiopathic pulmonary fibrosis management market is anticipated to grow at a CAGR of 1.5% from a market value of US$ 3145 million in 2023 to US$ 3649.90 million. The rising prevalence of the condition in men around the world is responsible for the expansion of …
Alpha-1 Antitrypsin Deficiency Market Booms to US$10 Billion by 2033, Propelled by a Noteworthy 12.8% CAGR | FMI Report
The global Alpha-1 Antitrypsin Deficiency market is poised to achieve a market value of US$3 billion in 2023, with projections indicating a remarkable growth to US$10 billion by 2033, driven by a substantial CAGR of 12.8% during the forecast period. The surge in respiratory illnesses plays a pivotal role in expanding the market. Furthermore, the …
FMI Reveals Remarkable Forecast for the Chronic Obstructive Pulmonary Disease (COPD): Expected to Reach US$33.19 Billion with a 4.4% CAGR by 2033
The worldwide market for Chronic Obstructive Pulmonary Disease (COPD) is anticipated to reach a substantial valuation of US$21.58 billion in the year 2023. As a consequence of the rising prevalence of alcohol consumption among individuals, the collective requirement for Chronic Obstructive Pulmonary Disease (COPD) is expected to experience a significant expansion, manifesting a commendable Compound …
FMI Report Predicts Remarkable 7.9% CAGR, Forecasting US$5.91 Billion Valuation for Dental Imaging Equipment Market by 2030
Future Market Insights (FMI) recently conducted a market survey, revealing a compelling growth trajectory for the global Dental Imaging Equipment Market. With a remarkable 7.9% Compound Annual Growth Rate (CAGR), the market is set to escalate from its 2021 valuation of US$2.99 Billion to a substantial US$5.91 Billion by the year 2030. Dental imaging equipment …
Breast Imaging Market’s Exceptional 7.1% CAGR Transformation, Predicting US$8.5 Billion by 2032 | FMI Analysis Revealed
In the Recent Study by Future Market Insights breast imaging market is poised for impressive growth at a 7.1% CAGR between 2022 and 2032, catapulting its value from US$4.3 billion in 2022 to a projected US$8.5 billion by 2032. This remarkable growth is propelled by several key factors, including the increasing prevalence and incidence of …
FMI’s Revealing Insights: Anemia Treatment Market on Track to Reach US$14.9 Billion by 2028, at an impressive CAGR of 6.9%.
In 2022, the Anemia Treatment Market is set to surpass the noteworthy benchmark of US$10.0 billion. Looking ahead to 2028, market analysts anticipate substantial growth, with a projected market value of US$14.9 billion, driven by robust sales growth at an impressive CAGR of 6.9%. A recent report from Future Market Insights underscores that a significant …
Hypercalcemia Treatment Market’s Ascent: Reaching US$18.07 Billion by 2023, Aiming for US$55.07 Billion by 2033 | Reveals by FMI
The worldwide hypercalcemia treatment market is poised to achieve a market value of US$18.07 billion by the conclusion of 2023. With a projected compound annual growth rate (CAGR) of 11.8% over the forecast period, the market is anticipated to surge to an impressive valuation of US$55.07 billion by the year 2033. The report on the …
FMI Reveals Lucrative Future for Dry Eye Syndrome Treatment Market, Projecting US$9.44 Billion Valuation by 2032
The global market for treating dry eye syndrome is poised for significant expansion. Estimated at US$ 4.80 Billion in 2022, it is forecasted to experience a robust compound annual growth rate (CAGR) of 7.0% from 2022 to 2032. This growth trajectory is expected to culminate in an impressive valuation of US$ 9.44 Billion by the …